Achieve Life Sciences (ACHV) Profit After Tax (2010 - 2026)
Achieve Life Sciences (ACHV) posted Profit After Tax of -$10.2 million for Q1 2026, up 30.36% on a QoQ basis from -$14.6 million in Q4 2025, and up 20.88% year-over-year from -$8.4 million in Q1 2025.
Achieve Life Sciences (ACHV) Profit After Tax (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Profit After Tax history runs 17 years deep, the most recent figure standing at -$10.2 million for Q1 2026.
- Quarterly Profit After Tax rose 20.88% year-over-year to -$10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.9 million (down 12.5% YoY) and the FY2025 annual result came in at -$54.6 million, down 37.09% from the prior year.
- Profit After Tax was -$10.2 million for Q1 2026 at Achieve Life Sciences, up from -$14.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$5.5 million in Q4 2023 and bottomed at -$14.6 million in Q4 2025.
- A 5-year average of -$10.4 million and a median of -$10.5 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax soared 51.25% — and 2024, when it slumped 125.11%.
- Achieve Life Sciences' Profit After Tax stood at -$11.2 million in 2022, then surged by 51.25% to -$5.5 million in 2023, then sank by 125.11% to -$12.3 million in 2024, then retreated by 18.44% to -$14.6 million in 2025, then surged by 30.36% to -$10.2 million in 2026.
- Business Quant data shows ACHV's Profit After Tax at -$10.2 million in Q1 2026, -$14.6 million in Q4 2025, and -$14.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | -10.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.17 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -14.44 Mn |
| Jun 30, 2025 | -12.72 Mn |
| Mar 31, 2025 | -12.85 Mn |
| Dec 31, 2024 | -12.33 Mn |
| Sep 30, 2024 | -12.51 Mn |
| Jun 30, 2024 | -8.46 Mn |
| Mar 31, 2024 | -6.49 Mn |
| Dec 31, 2023 | -5.48 Mn |
| Sep 30, 2023 | -7.11 Mn |
| Jun 30, 2023 | -8.24 Mn |
| Mar 31, 2023 | -8.99 Mn |
| Dec 31, 2022 | -11.23 Mn |
| Sep 30, 2022 | -13.08 Mn |
| Jun 30, 2022 | -10.47 Mn |
| Mar 31, 2022 | -7.57 Mn |
| Dec 31, 2021 | -7.15 Mn |
| Sep 30, 2021 | -6.69 Mn |
| Jun 30, 2021 | -11.31 Mn |